About UnitedHealth Group Incorporated
UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum. UnitedHealthcare provides healthcare benefits to a range of customers and markets through its UnitedHealthcare Employer & Individual, UnitedHealthcare Medicare & Retirement, UnitedHealthcare Community & State, and UnitedHealthcare Global businesses. Optum is a health services business serving the healthcare marketplace, including payers, care providers, employers, governments, life sciences companies and consumers, through its OptumHealth, OptumInsight and OptumRx businesses.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Health Care Plans
- Sub-Industry: Managed Health Care
- Exchange: NYSE
- Symbol: UNH
- CUSIP: 91324P10
- Previous Close: $157.62
- 50 Day Moving Average: $161.25
- 200 Day Moving Average: $149.06
- 52-Week Range: $112.53 - $164.00
- Trailing P/E Ratio: 21.74
- Foreward P/E Ratio: 14.81
- P/E Growth: 1.03
- Market Cap: $149.92B
- Outstanding Shares: 951,165,000
- Beta: 0.68
- Net Margins: 3.92%
- Return on Equity: 21.20%
- Return on Assets: 6.44%
Companies Related to UnitedHealth Group Incorporated:
- Debt-to-Equity Ratio: 0.68%
- Current Ratio: 0.69%
- Quick Ratio: 0.69%
What is UnitedHealth Group Incorporated's stock symbol?
UnitedHealth Group Incorporated trades on the New York Stock Exchange (NYSE) under the ticker symbol "UNH."
How often does UnitedHealth Group Incorporated pay dividends? What is the dividend yield for UnitedHealth Group Incorporated?
UnitedHealth Group Incorporated announced a quarterly dividend on Thursday, February 9th. Investors of record on Friday, March 10th will be paid a dividend of $0.625 per share on Tuesday, March 21st. This represents a $2.50 annualized dividend and a yield of 1.59%. The ex-dividend date of this dividend is Wednesday, March 8th.
Where is UnitedHealth Group Incorporated's stock going? Where will UnitedHealth Group Incorporated's stock price be in 2017?
21 brokerages have issued 12-month price targets for UnitedHealth Group Incorporated's stock. Their predictions range from $155.00 to $200.00. On average, they anticipate UnitedHealth Group Incorporated's stock price to reach $174.50 in the next twelve months.
When will UnitedHealth Group Incorporated announce their earnings?
UnitedHealth Group Incorporated is scheduled to release their next quarterly earnings announcement on Tuesday, January, 17th 2017.
What are analysts saying about UnitedHealth Group Incorporated stock?
Here are some recent quotes from research analysts about UnitedHealth Group Incorporated stock:
According to Zacks Investment Research, "UnitedHealth’s better-than-expected earnings were driven by strong results from both UnitedHealth Care and Optum segments. The company also reaffirmed the previously issued guidance for 2017, backed by stable medical costs, higher contribution from Optum and decline in exposure from its public exchange business. Shares of the company outperformed the Zacks categorized Medical Health Maintainence Organization industry. The company is consistently gaining from the Medicaid and Medicare businesses. Continued growth at Optum is also creating a diversified revenue source. The segment should see further growth from the Catamaran acquisition. Also, UnitedHealth should benefit from its capital strength and niche market position. Regular share buybacks and dividend increases are other positives. However, losses on public exchange business and higher operating costs are headwinds." (2/7/2017)
- Cantor Fitzgerald analysts commented, "We are transferring coverage of UnitedHealth Group (UNH) and rate the shares at Overweight. Our 12-month DCF-based price target is $200, representing about 24% upside. The company is nicely diversified within its UnitedHealthcare (UHC) health insurance segment. The reduction in losses relating to individual exchange plans should help UNH post solid bottom line growth in 2017. UNH is unique within our coverage universe given its Optum segment which accounted for 42% of consolidated operating profit in 2016. We expect continued strong growth in Optum in 2017. UNH should be a core holding in all large cap growth portfolios." (2/6/2017)
Credit Suisse Group analysts commented, "With phase I data for Radius’s SERD RAD1901 coming at SABCS next week, we wanted to share our thoughts heading into the data. Our top incoming question has been how many responses will we see?" and while management comments have been limited to the term multiple responses" our base case heading into the meeting is that we see responses in 3 of the 23 patients for whom we expect to see data (n=20 in expansion cohort and n=3 in the FES-PET study). To the extent this data looks encouraging and supports continued development, we believe the Street could begin to ascribe more value to the asset, which in our DCF accounts for $12/share of value (25% prob of $750mm peak sales). Beyond SABCS, we continue to expect approval for lead asset abaloparatide (osteoporosis) on March 30 and a positive CHMP opinion late-2016/early-2017." (11/30/2016)
Who owns UnitedHealth Group Incorporated stock?
UnitedHealth Group Incorporated's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include FMR LLC (5.75%), State Street Corp (4.60%), Fiduciary Management Inc. WI (0.41%), AQR Capital Management LLC (0.39%), Davis Selected Advisers (0.32%) and Dimensional Fund Advisors LP (0.31%). Company insiders that own UnitedHealth Group Incorporated stock include D Ellen Wilson, Gail R Wilensky, Kenneth Irwin Shine, Richard T Burke, Stephen J Hemsley, William C Ballard Jr and William C Ballard, Jr.
Who sold UnitedHealth Group Incorporated stock? Who is selling UnitedHealth Group Incorporated stock?
UnitedHealth Group Incorporated's stock was sold by a variety of institutional investors in the last quarter, including Investec Asset Management LTD, Barrow Hanley Mewhinney & Strauss LLC, Vulcan Value Partners LLC, Fred Alger Management Inc., Arrowstreet Capital Limited Partnership, Orbimed Advisors LLC, Janus Capital Management LLC and Santa Barbara Asset Management LLC. Company insiders that have sold UnitedHealth Group Incorporated stock in the last year include D Ellen Wilson, Gail R Wilensky, Kenneth Irwin Shine, Richard T Burke and William C Ballard Jr.
Who bought UnitedHealth Group Incorporated stock? Who is buying UnitedHealth Group Incorporated stock?
UnitedHealth Group Incorporated's stock was acquired by a variety of institutional investors in the last quarter, including State Street Corp, Viking Global Investors LP, Russell Investments Group Ltd., Asset Management One Co. Ltd., Marshall Wace LLP, AQR Capital Management LLC, FMR LLC and Congress Asset Management Co. MA.
How do I buy UnitedHealth Group Incorporated stock?
Shares of UnitedHealth Group Incorporated can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of UnitedHealth Group Incorporated stock cost?
One share of UnitedHealth Group Incorporated stock can currently be purchased for approximately $157.62.